Clinical trial
Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
NCT07824089 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
- Lead sponsor
- The Cleveland Clinic
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 25, 2026
- Completion date
- December 31, 2031
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol related liver disease, alcohol use disorder (aud)